160 related articles for article (PubMed ID: 29359883)
1. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
[TBL] [Abstract][Full Text] [Related]
2. A Statewide Intervention Improves Appropriate Imaging in Localized Prostate Cancer.
Hurley P; Dhir A; Gao Y; Drabik B; Lim K; Curry J; Womble PR; Linsell SM; Brachulis A; Sexton DW; Ghani KR; Denton BT; Miller DC; Montie JE;
J Urol; 2017 May; 197(5):1222-1228. PubMed ID: 27889418
[TBL] [Abstract][Full Text] [Related]
3. Regional collaboration to improve radiographic staging practices among men with early stage prostate cancer.
Miller DC; Murtagh DS; Suh RS; Knapp PM; Schuster TG; Dunn RL; Montie JE
J Urol; 2011 Sep; 186(3):844-9. PubMed ID: 21788043
[TBL] [Abstract][Full Text] [Related]
4. Unnecessary imaging for the staging of low-risk prostate cancer is common.
Lavery HJ; Brajtbord JS; Levinson AW; Nabizada-Pace F; Pollard ME; Samadi DB
Urology; 2011 Feb; 77(2):274-8. PubMed ID: 20932557
[TBL] [Abstract][Full Text] [Related]
5. MUSIC: patterns of care in the radiographic staging of men with newly diagnosed low risk prostate cancer.
Ross I; Womble P; Ye J; Linsell S; Montie JE; Miller DC; Cher ML
J Urol; 2015 Apr; 193(4):1159-62. PubMed ID: 25444985
[TBL] [Abstract][Full Text] [Related]
6. Establishing the pathways and indications for performing isotope bone scans in newly diagnosed intermediate-risk localised prostate cancer - results from a large contemporaneous cohort.
KandaSwamy GV; Bennett A; Narahari K; Hughes O; Rees J; Kynaston H
BJU Int; 2017 Nov; 120(5B):E59-E63. PubMed ID: 28317247
[TBL] [Abstract][Full Text] [Related]
7. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
8. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
[TBL] [Abstract][Full Text] [Related]
9. Quantifying downstream impact of inappropriate staging imaging in a cohort of veterans with low- and intermediate-risk incident prostate cancer.
Drangsholt S; Walter D; Ciprut S; Lepor A; Sedlander E; Curnyn C; Loeb S; Malloy P; Winn AN; Makarov DV
Urol Oncol; 2019 Feb; 37(2):145-149. PubMed ID: 30578160
[TBL] [Abstract][Full Text] [Related]
10. Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [(18)F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis.
Evangelista L; Cimitan M; Zattoni F; Guttilla A; Zattoni F; Saladini G
Scand J Urol; 2015; 49(5):345-53. PubMed ID: 25649494
[TBL] [Abstract][Full Text] [Related]
11. Are staging investigations being overused in patients with low and intermediate risk prostate cancer?
Kim L; Min M; Roos D; Nguyen L; Yeoh E
J Med Imaging Radiat Oncol; 2015 Feb; 59(1):77-81. PubMed ID: 25186469
[TBL] [Abstract][Full Text] [Related]
12. Use of bone scan during initial prostate cancer workup, downstream procedures, and associated Medicare costs.
Falchook AD; Salloum RG; Hendrix LH; Chen RC
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):243-8. PubMed ID: 24321784
[TBL] [Abstract][Full Text] [Related]
13. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
Cooperberg MR; Lubeck DP; Grossfeld GD; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):491-5. PubMed ID: 12131295
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with imaging in patients with early breast cancer after initial treatment.
Enright K; Desai T; Sutradhar R; Gonzalez A; Powis M; Taback N; Booth CM; Trudeau ME; Krzyzanowska MK
Curr Oncol; 2018 Apr; 25(2):126-132. PubMed ID: 29719428
[TBL] [Abstract][Full Text] [Related]
15. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database.
Kindrick AV; Grossfeld GD; Stier DM; Flanders SC; Henning JM; Carroll PR
J Urol; 1998 Dec; 160(6 Pt 1):2102-6. PubMed ID: 9817332
[TBL] [Abstract][Full Text] [Related]
16. Imaging and evaluation of patients with high-risk prostate cancer.
Bjurlin MA; Rosenkrantz AB; Beltran LS; Raad RA; Taneja SS
Nat Rev Urol; 2015 Nov; 12(11):617-28. PubMed ID: 26481576
[TBL] [Abstract][Full Text] [Related]
17. Prospective evaluation of 68Gallium-prostate-specific membrane antigen positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer.
van Leeuwen PJ; Emmett L; Ho B; Delprado W; Ting F; Nguyen Q; Stricker PD
BJU Int; 2017 Feb; 119(2):209-215. PubMed ID: 27207581
[TBL] [Abstract][Full Text] [Related]
18. Combined 18F-fluorocholine and 18F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer.
Kjölhede H; Ahlgren G; Almquist H; Liedberg F; Lyttkens K; Ohlsson T; Bratt O
BJU Int; 2012 Nov; 110(10):1501-6. PubMed ID: 22502982
[TBL] [Abstract][Full Text] [Related]
19. Establishment of a urological surgery quality collaborative.
Miller DC; Murtagh DS; Suh RS; Knapp PM; Dunn RL; Montie JE
J Urol; 2010 Dec; 184(6):2485-90. PubMed ID: 20961582
[TBL] [Abstract][Full Text] [Related]
20. Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.
Salloum RG; O'Keeffe-Rosetti M; Ritzwoller DP; Hornbrook MC; Lafata JE; Nielsen ME
J Oncol Pract; 2017 May; 13(5):e441-e450. PubMed ID: 28221895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
